Osteo Drug May Prevent Breast Cancer
614905
TUESDAY, Nov. 30 (HealthDayNews) -- If you're taking raloxifene (Evista) because you have osteoporosis, a new study finds a probable added benefit: The drug may also significantly reduce your risk of developing breast cancer.
160373
Breast cancer survivors now have another drug that can help keep the disease from coming back. Femara is prescribed to fight advanced breast cancer.
14
A new type of drug shows growing promise as a more potent way for many breast cancer patients to significantly cut their risk of a recurrence, researchers reported yesterday.
145071
A drug used to treat breast cancer would not be good for preventing the tumours occurring in the first place, say researchers.
143676
An experimental treatment for bone-thinning osteoporosis appears to prevent spine and hip fractures even though it is given only once a year, eliminating the need for a strict daily pill regimen, preliminary data show.
397182
SAN ANTONIO - Dec. 9, 2004 â-esults of an ogoing study show that a new class of drug called aromatase inhibitors can cut the rate of breast cancer recurrence by 76 percent in certain older women.
233800
New research shows that a set of simple questions may help primary-care practitioners identify which women would benefit from a more elaborate discussion of tamoxifen, a drug that can help prevent breast cancer.
124008
NEW YORK  - In a mouse model of breast cancer, the COX-2 inhibitor celecoxib (Celebrex) prevents chronic morphine-induced effects on tumor growth without compromising pain relief, scientists report.
98244
Most women who have breast cancer and are past menopause should take a type of hormone-blocking drug known as an aromatase inhibitor to prevent cancer recurrence, experts said Monday.
399351
NEW YORK  - A drug used to restore the strength of brittle bones by reducing the process of bone resorption has been shown to benefit women 80 years of age or older.
542831
British women who have had breast cancer can now have a new treatment which has been found to prevent the disease returning and to prolong survival.
156055
TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast cancer drugs, called aromatase inhibitors, after two to three years of treatment with tamoxifen may extend disease-free survival and slightly reduce the risk of death in women who've been treated for early stage disease, an international study finds.
191767
THURSDAY, Feb 10 (HealthDay News) -- A compound derived from a rare South American plant shows promise as a treatment for breast cancer, according to a University of Virginia Health System study.
642497
NEW YORK  - Treatment with a drug used to  combat the bone-thinning disease osteoporosis appears to reduce  the occurrence of osteoarthritis-related damage in the knee,  according to a new report.
264861
Osteoporosis drug could give the company its next big winner.
458956
Tamoxifen reduces the risk of breast cancer returning long after women stop taking the drug, research suggests.
396092
TUESDAY, July 17 (HealthDay News) -- Taking a pricey breast cancer drug called lapatinib (Tykerb) with food rather than on an empty stomach may improve its absorption by the body -- lowering the doses needed and greatly cutting costs for patients, a new study shows.